AbbVie Inc.
Price Action
Technical Summary
CONSOLIDATINGAbbVie Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is moderate (RS Rating: 74), indicating performance broadly in line with the market. Earnings contraction of 46% provides fundamental context to the price action. Volume support will be critical for the stock to resolve this consolidation to the upside.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $236.48 | +7.69% | ABOVE |
| 50 SMA | $220.76 | +15.35% | ABOVE |
| 100 SMA | $219.15 | +16.20% | ABOVE |
| 150 SMA | $220.68 | +15.39% | ABOVE |
| 200 SMA | $222.37 | +14.52% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is ABBV in an uptrend right now?
ABBV has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.
Is ABBV overbought or oversold?
ABBV's RSI (14) is 69. The stock is in neutral territory, neither overbought nor oversold.
Is ABBV outperforming the market?
ABBV has a Relative Strength (RS) Rating of 74 out of 99. ABBV is performing about average compared to the market.
Where is ABBV in its 52-week range?
ABBV is trading at $254.65, which is 97% of its 52-week high ($261.63) and 91% above its 52-week low ($184.63).
How volatile is ABBV?
ABBV has a Beta of 0.02 and 52-week volatility of 26%. It's less volatile than the S&P 500 - generally more stable.